Samuel J. Reich, Executive Chairman: SAB Biotherapeutics SABS Buy · Filed 23/11/30

Trade details

Type: Insider buy
Amount: $9,790
Shares · price: 11,000 sh · $0.89 a share
Held after: 219,001 sh
Stock: SAB Biotherapeutics SABS
Person: Samuel J. ReichExecutive Chairman
Trade date: 23/11/29
Filed: 23/11/30
Days to filing: 1 days

2 insiders bought this week

Insiders buying this week: 2 insiders
Holding change: +5.3%

SAB Biotherapeutics trades, last 26 weeks

What else happened in SAB Biotherapeutics around then

Filed or reported within 30 days of the trade day · 23/10/30~23/12/29

Samuel J. Reich's recent trades

No other trades yet.